XYLOCAINE JELLY 2%

Kraj: Singapur

Język: angielski

Źródło: HSA (Health Sciences Authority)

Składnik aktywny:

LIGNOCAINE HCl

Dostępny od:

DCH AURIGA SINGAPORE

Kod ATC:

N01BB02

Dawkowanie:

20 mg/g

Forma farmaceutyczna:

GEL

Skład:

LIGNOCAINE HCl 20 mg/g

Droga podania:

TOPICAL

Typ recepty:

General Sale List

Wyprodukowano przez:

Recipharm Karlskoga AB

Status autoryzacji:

ACTIVE

Data autoryzacji:

1991-04-08

Ulotka dla pacjenta

05/AC/SG/PAIN.000-078-338.6.0
Xylocaine Jelly 2%
_lidocaine hydrochloride _
Jelly
Composition
_Active constituent: _
Pharmaceutical form
Xylocaine jelly is a clear to almost clear, slightly coloured
jelly. The vehicle of the active ingredient consists of water
thickened with hydroxypropyl methylcellulose. Jelly syringes
are free from preservatives. Jelly in tubes contains methyl
parahydroxybensoate and propyl parahydroxybensoate.
Indications
Xylocaine jelly is indicated as a surface anaesthetic and
lubricant for:
-
The male and female urethra during cystoscopy,
catheterisation, exploration by sound and other
endourethral procedures.
-
Nasal and pharyngeal cavities in endoscopic procedures
such as gastroscopy and bronchoscopy.
-
During proctoscopy and rectoscopy.
-
Tracheal intubation.
-
Symptomatic treatment of pain in connection with cystitis
and urethritis.
Dosage and method of administration
Xylocaine jelly 2% provides prompt and profound anaesthesia
of mucous membranes, giving effective anaesthesia of long
As with any local anaesthetic, the safety and effectiveness of
lidocaine depend on the proper dosage, the correct technique,
adequate precautions and readiness for emergencies.
The following dosage recommendations should be regarded
as a guide. The clinician’s experience and knowledge of the
patient’s physical status are of importance in calculating the
required dose.
Absorption from mucous membranes is variable but
especially high from the bronchial tree. The absorption of
lidocaine jelly from the nasopharynx is usually lower than with
other lidocaine products. Blood concentrations of lidocaine
after instillation of the jelly in the intact urethra and bladder in
doses up to 800 mg are fairly low and below toxic levels.
Debilitated or elderly patients, children over 12 years of age,
acutely ill patients or patients with sepsis should be given
doses commensurate with their age, weight and physical
condition.
In children under the age of 12 years the dose should not
exceed 4 mg/kg.
Urethral anaesthesia
Su

Charakterystyka produktu

05/AC/SG/PAIN.000-078-338.6.0
Xylocaine Jelly 2%
_lidocaine hydrochloride _
Jelly
Composition
_Active constituent: _
Pharmaceutical form
Xylocaine jelly is a clear to almost clear, slightly coloured
jelly. The vehicle of the active ingredient consists of water
thickened with hydroxypropyl methylcellulose. Jelly syringes
are free from preservatives. Jelly in tubes contains methyl
parahydroxybensoate and propyl parahydroxybensoate.
Indications
Xylocaine jelly is indicated as a surface anaesthetic and
lubricant for:
-
The male and female urethra during cystoscopy,
catheterisation, exploration by sound and other
endourethral procedures.
-
Nasal and pharyngeal cavities in endoscopic procedures
such as gastroscopy and bronchoscopy.
-
During proctoscopy and rectoscopy.
-
Tracheal intubation.
-
Symptomatic treatment of pain in connection with cystitis
and urethritis.
Dosage and method of administration
Xylocaine jelly 2% provides prompt and profound anaesthesia
of mucous membranes, giving effective anaesthesia of long
As with any local anaesthetic, the safety and effectiveness of
lidocaine depend on the proper dosage, the correct technique,
adequate precautions and readiness for emergencies.
The following dosage recommendations should be regarded
as a guide. The clinician’s experience and knowledge of the
patient’s physical status are of importance in calculating the
required dose.
Absorption from mucous membranes is variable but
especially high from the bronchial tree. The absorption of
lidocaine jelly from the nasopharynx is usually lower than with
other lidocaine products. Blood concentrations of lidocaine
after instillation of the jelly in the intact urethra and bladder in
doses up to 800 mg are fairly low and below toxic levels.
Debilitated or elderly patients, children over 12 years of age,
acutely ill patients or patients with sepsis should be given
doses commensurate with their age, weight and physical
condition.
In children under the age of 12 years the dose should not
exceed 4 mg/kg.
Urethral anaesthesia
Su